Site-specific analysis of the SARS-CoV-2 glycan shield

The emergence of the betacoronavirus, SARS-CoV-2 that causes COVID-19, represents a significant threat to global human health. Vaccine development is focused on the principal target of the humoral immune response, the spike (S) glycoprotein, that mediates cell entry and membrane fusion. SARS-CoV-2 S...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Yasunori, Allen, Joel D., Wrapp, Daniel, McLellan, Jason S., Crispin, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239077/
https://www.ncbi.nlm.nih.gov/pubmed/32511336
http://dx.doi.org/10.1101/2020.03.26.010322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239077/
https://www.ncbi.nlm.nih.gov/pubmed/32511336
http://dx.doi.org/10.1101/2020.03.26.010322

Ejemplares similares